advertisement

Topcon

11.16 Vehicles, delivery systems, pharmacokinetics, formulation (11)

Showing records 1 to 11

Display all abstracts in classification 11.16 Vehicles, delivery systems, pharmacokinetics, formulation

Search within classification 11.16 Vehicles, delivery systems, pharmacokinetics, formulation
22873 Quantitative analysis of conjunctival goblet cells after chronic application of topical drops
Kahook MY; Noecker R
Advances in Therapy 2008; 25: 743-751
22842 Poly (ε-caprolactone) microparticles containing Levobunolol HCl prepared by a multiple emulsion (W/O/W) solvent evaporation technique: Effects of some formulation parameters on microparticle characteristics
Karatas A; Sonakin OOzlem; KiliCarslan M; Baykara T
Journal of Microencapsulation 2009; 26: 63-74
22885 Ophthalmic timolol in a hydrogel vehicle leads to minor inter-individual variation in timolol concentration in aqueous humor
Volotinen M; Maenpaa J; Kautiainen H; Tolonen A; Uusitalo J; Ropo A; Vapaatalo H; Aine E
European Journal of Pharmaceutical Sciences 2009; 36:-3 292-296
22764 Tear film and ocular surface alterations in chronic users of antiglaucoma medications
Baffa LP; Ricardo JR; Dias AC; Modulo CM; Braz AM; Paula JS; Rodrigues ML; Rocha EM
Arquivos Brasileiros de Oftalmologia 2008; 71: 18-21
22827 Polyoxyethylated nonionic surfactants and their applications in topical ocular drug delivery
Jiao J
Advanced Drug Delivery Reviews 2008; 60: 1663-1673
22642 Dosage variability of topical ocular hypotensive products: a densitometric assessment
Gaynes BI; Singa RM; Cao Y
Journal of Glaucoma 2009; 18: 149-152
22965 Poly (epsilon-caprolactone) microparticles containing Levobunolol HCl prepared by a multiple emulsion (W/O/W) solvent evaporation technique: effects of some formulation parameters on microparticle characteristics
Karatas A; Sonakin O; KiliCarslan M; Baykara T
Journal of Microencapsulation 2009; 26: 63-74
22755 Development of ocular drug delivery systems
Saska Z; Hajdu M; Laki M; Klebovich I; Antal I
Acta Pharmaceutica Hungarica 2008; 78: 156-164
23365 Ophthalmic formulations of the intraocular hypotensive melatonin agent 5-MCA-NAT
Andrés-Guerrero V; Alarma-Estrany P; Molina-Martínez IT; Peral A; Herrero-Vanrell R; Pintor J
Experimental Eye Research 2009; 88: 504-511
22843 Sustained delivery of timolol maleate from poly(lactic-co-glycolic acid)/ poly(lactic acid) microspheres for over 3 months
Bertram JP; Saluja SS; McKain J; Lavik EB
Journal of Microencapsulation 2009; 26: 18-26
22676 Corneal penetration into rabbit aqueous humor is comparable between preserved and preservative-free tafluprost
Pellinen P; Lokkila J
Ophthalmic Research 2009; 1: 118-122

Issue 11-1

Change Issue


advertisement

Oculus